Team

What's our secret? Great people.​

Specialized skills – Competence heterogeneity – Bold vision –
Cohesion and Collaboration – Responsibility

Mario Napolitano

CEO
Chartered Accountant, Statutory Auditor, Technical Consultant, Delegated Professional and Judicial Custodian, member of the Supervisory Body

Lucia Altucci

Scientific Director
MD, PhD and professor of General Pathology, more than 20 years of experience and more than 170 scientific publications on epigenetics.

Gianluigi Franci

Research and Development
PhD, professor of Microbiology and Clinical Microbiology. Head of the Clinical Program: “Advanced diagnostics for microbial resistance”. 3X entrepreneur.

Carlo Altucci

Research and Development
"PhD, professor of Biomedical Physics and Bio-Photonics specialized in Bionanophotonics (nano-phor.unina.it) and prototyping bio-sensor. For Epi-C has developed an innovative mobile sensor for proper detection of pollutants, applicable to transports and cars"

Francesco Izzo

Strategy & Marketing
PhD, professor of Strategic Management of Innovation. His research activity is focused on innovation management, growth strategy, entrepreneurship.

Massimo Mallardo

Research and Development
PhD, post-doctoral at EMBL, Cell Biology program, Heidelberg, Germany, and at Max-Planck Institute for Developmental Biology, Protein Evolution Department, Tuebingen, Germany.

Marco Ferretti

Research and Business Development
Marco Ferretti holds the chair of Corporate Strategy and Innovation Management at Università degli studi di Napoli Parthenope

Vincenzo Vecchio

Business Development
Engineer, founder and co-founfer of Italian and US-based start-ups, Business Coach for the European Commission, with international project management experience.

Cinzia Cannizzaro

In charge of planning, management and control and legal aspects. Technical and professional consultant for EU funded projects for public institutions and private companies.

Rosaria Benedetti

Research and Development
PhD, RTDA, her research interests involve the development of a comprehensive understanding of key developmental pathways and how alterations in gene expression contribute to human disease, in particular cancer.

Carmela Dell'Aversana

Research and Development
PhD, researcher at CNR, her research is addressed to deciphere cellular dynamics and functional role of many epigenetic and post-translational mechanisms, mainly miRNA, and extracellular vesicle-mediated cellular communications in human disease, mainly in chemoresistant cancers.

Federica Sarno

Research and Development
PhD, post-doc, her research interests are focused on HTS drug discovery, in particular for KDM4A modulators.

Mariarosaria Conte

Research and Development
PhD, RTDA, her research is mainly focused the role of chromatin modifiers (in particular histone deacetylases) in carcinogenesis and in immune modulation.

Francesca Cuomo

Research and Development
Master’s Degree in Medical Biotechnology cum laude, University of Naples, Federico II. PhD in Translational Medicine, University of Campania Luigi Vanvitelli.

Angela Nebbioso

Research and Development
PhD, professor of General Pathology, her pre-clinically oriented research is based both on anticancer epigenetic drug development and on the characterization of the mechanisms of tumorigenesis and leukemogenesis.

Michele Monna

Sales Manager
Italy’s Sales Manager at Microtech Experiences in sales field and personnel management.